REFERENCES
J. Kao and M. P. Carver. Cutaneous metabolism of xenobiotics. Drug Metab. Rev. 22:363–410 (1990).
J. Kao, F. K. Patterson, and J. Hall. Skin penetration and metabolism of topically applied chemicals in six mammalian species, including man: An in vitro study with benzo[a]pyrene and testosterone. Toxicol. Appl. Pharmacol. 81:502–516 (1985).
J. Kao, J. Hall, L. R. Shugart, and J. M. Holland. An in vitro approach to studying cutaneous metabolism and disposition of topically applied xenobiotics. Toxicol. Appl. Pharmacol. 75:289–298 (1984).
P. R. Ortiz De Montellano and J. M. Matthews. Autocatalytic alkylation of the cytochrome P-450 prosthetic haem group by 1-aminobenzotriazole. Biochem. J. 195:761–764 (1981).
J. C. Huijzer, J. D. Adams, J.-Y. Jaw, and G. S. Yost. Inhibition of 3-methylindole bioactivation by the cytochrome P-450 suicide substrates 1-aminobenzotriazole and α-methylbenzyl-aminobenzotriazole. Drug Metab. Disp. 17:37–42 (1989).
B. A. Mico, D. A. Federowicz, M. G. Ripple, and W. Kerns. In vivo inhibition of oxidative drug metabolism by, and acute toxicity of, 1-aminobenzotriazole (ABT). Biochem. Pharmacol. 37:2515–2519 (1988).
P. R. Ortiz De Montellano and J. M. Mathews. Autocatalytic alkylation of the cytochrome P-450 prosthetic haem group by 1-aminobenzotriazole. Biochem. J. 195:761–764 (1981).
C. D. Campbell and C. W. Rees. Reactive intermediates. 1. Synthesis and oxidation of 1-and 2-aminobenzotriazole. J. Chem. Soc. (c) 742–747 (1969).
N. Oldfield. The metabolic fate of 13-cis retinoic acid (Isotretinoin) in mouse skin microsomal preparations. Drug Metab. Disp. 18:1105–1107 (1990).
O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275 (1951).
M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254 (1976).
R. W. Estabrook, J. Peterson, J. Baron, and A. Hildebrandt. The spectrophotometric measurement of turbid suspensions of cytochromes associated with drug metabolism. Methods Pharmacol. 2:303–350 (1972).
A. E. Rettie, F. M. Williams, M. D. Rawlins, R. T. Mayer, and M. D. Burke. Major differences between lung, skin and liver in the microsomal metabolism of homologous series of resorufin and coumarin ethers. Biochem. Pharmacol. 35:3495–3500 (1986).
D. R. Bickers, J. Eiseman, A. Kappas, and A. P. Alveres. Microscope immersion oils. Effects of skin application on cutaneous and hepatic drug-metabolizing enzymes. Biochem. Pharmacol. 24:779–783 (1975).
A. E. Rettie, F. M. Williams, and M. D. Rawlins. Substrate specificity of the mouse skin mixed-function oxidase system. Xenobiotica 16:205–211 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oldfield, N.F., Mortillo, M., Garland, W.A. et al. Inhibition of Hepatic and Cutaneous Biotransformation of Resorufin Ethers Following Intraperitoneal Administration of 1-Aminobenzotriazole. Pharm Res 9, 1099–1102 (1992). https://doi.org/10.1023/A:1015827100111
Issue Date:
DOI: https://doi.org/10.1023/A:1015827100111